MicroRNA (miR) profiling of the MERLIM-TIMI 36 cohort

This study aims to identify circulationg miR that could predict cardiovascular outcomes in patients who developed acute coronary syndrome. Plasma samples from 4,541 participants was used in quantification of 21 candidate miRs. Primary outcome include hospitalization for heart failure and cardiovascular death. 21 candidate miRNAs: hsa-mir-22-3p, hsa-mir-320a, hsa-mir-100-5p, hsa-mir-194-5p, hsa-mir-146a-5p, hsa-mir-146b-5p, hsa-mir-150-5p, hsa-mir-151a-3p, hsa-mir-21-5p, hsa-mir-223-3p, hsa-mir-29c-3p, hsa-mir-30a-5p, hsa-mir-30d-5p, hsa-mir-378c, hsa-mir-423-5p, hsa-mir-92a-3p, hsa-mir-106b-5p, hsa-mir-29a-3p, hsa-let-7g-5p, hsa-mir-103a-3p, hsa-mir-140-3p